AI in genomics offers transformative opportunities by enhancing drug discovery and personalized medicine through efficient genomic data analysis. Drivers include the surge in genomic data, the focus ...

Researchers at the Lawrence Berkeley National Laboratory have developed a design and training framework ...

What if the thermal noise that hinders the efficiency of both classical and quantum computers could, instead, be used as a ...

Overview AI medical diagnosis can recognize disease patterns even before symptoms worsenPredictive healthcare models delve into risk factors over the long termM ...

The deal could be worth more than $1 billion, if all genetic targets identified lead to approved therapeutics.

This week's round-up of pharma licensing deals features alliances involving Tenaya Therapeutics, Sino Bio, Antengene, and A2A ...

Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.

Glucose dysregulation may drive cerebral small vessel disease progression through microstructural brain damage, according to ...

Researchers from Duke Health and the University of Minnesota recently discovered that measuring specific tiny genetic ...

Ports across the Mediterranean are facing a mounting engineering dilemma as rising sea levels and intensifying storm patterns ...

When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or only MSI-positive tumors, accuracy fell substantially, revealing that the ...

Tenaya leverages “human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) with high-throughput in vitro screening, imaging analysis, and machine learning algorithms” to identify new ...